These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 35107741

  • 1. Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling.
    Liu X, Zhang Y, Ma C, Lin J, Du J.
    Mol Biol Rep; 2022 Apr; 49(4):3113-3122. PubMed ID: 35107741
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Alternate-day fasting protects the livers of mice against high-fat diet-induced inflammation associated with the suppression of Toll-like receptor 4/nuclear factor κB signaling.
    Yang W, Cao M, Mao X, Wei X, Li X, Chen G, Zhang J, Wang Z, Shi J, Huang H, Yao X, Liu C.
    Nutr Res; 2016 Jun; 36(6):586-93. PubMed ID: 27188904
    [Abstract] [Full Text] [Related]

  • 4. Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis.
    Qiu H, Song E, Hu Y, Li T, Ku KC, Wang C, Cheung BMY, Cheong LY, Wang Q, Wu X, Hoo RLC, Wang Y, Xu A.
    Cell Mol Gastroenterol Hepatol; 2022 Jun; 14(5):1003-1023. PubMed ID: 35931383
    [Abstract] [Full Text] [Related]

  • 5. Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway.
    Wu YK, Ren ZN, Zhu SL, Wu YZ, Wang G, Zhang H, Chen W, He Z, Ye XL, Zhai QX.
    Acta Pharmacol Sin; 2022 Jun; 43(6):1473-1483. PubMed ID: 34654875
    [Abstract] [Full Text] [Related]

  • 6. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway.
    Wang ZQ, Zhang XH, Yu Y, Tipton RC, Raskin I, Ribnicky D, Johnson W, Cefalu WT.
    Metabolism; 2013 Sep; 62(9):1239-49. PubMed ID: 23702383
    [Abstract] [Full Text] [Related]

  • 7. Fibroblast growth factor 21 reflects liver fat accumulation and dysregulation of signalling pathways in the liver of C57BL/6J mice.
    Rusli F, Deelen J, Andriyani E, Boekschoten MV, Lute C, van den Akker EB, Müller M, Beekman M, Steegenga WT.
    Sci Rep; 2016 Jul 29; 6():30484. PubMed ID: 27470139
    [Abstract] [Full Text] [Related]

  • 8. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C, Schönke M, Spoorenberg B, Lambooij JM, van der Zande HJP, Zhou E, Tushuizen ME, Andreasson AC, Park A, Oldham S, Uhrbom M, Ahlstedt I, Ikeda Y, Wallenius K, Peng XR, Guigas B, Boon MR, Wang Y, Rensen PCN.
    Elife; 2023 Jan 17; 12():. PubMed ID: 36648330
    [Abstract] [Full Text] [Related]

  • 9. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
    Xie Y, Jin Y, Wen J, Li G, Huai X, Duan Y, Ni F, Fu J, Li M, Li L, Yan M, Cao L, Xiao W, Yang H, Wang ZZ.
    Biomed Pharmacother; 2024 Jul 17; 176():116908. PubMed ID: 38850668
    [Abstract] [Full Text] [Related]

  • 10. Fenofibrate alleviates NAFLD by enhancing the PPARα/PGC-1α signaling pathway coupling mitochondrial function.
    Wang X, Wang J, Ying C, Xing Y, Su X, Men K.
    BMC Pharmacol Toxicol; 2024 Jan 03; 25(1):7. PubMed ID: 38173037
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Exposure to Succinate Leads to Steatosis in Non-Obese Non-Alcoholic Fatty Liver Disease by Inhibiting AMPK/PPARα/FGF21-Dependent Fatty Acid Oxidation.
    Yang H, Ran S, Zhou Y, Shi Q, Yu J, Wang W, Sun C, Li D, Hu Y, Pan C, Yuan Q, Zhen Y, Liu Q, Song L.
    J Agric Food Chem; 2024 Sep 25; 72(38):21052-21064. PubMed ID: 39268842
    [Abstract] [Full Text] [Related]

  • 13. Role of fibroblast growth factor 21 in the early stage of NASH induced by methionine- and choline-deficient diet.
    Tanaka N, Takahashi S, Zhang Y, Krausz KW, Smith PB, Patterson AD, Gonzalez FJ.
    Biochim Biophys Acta; 2015 Jul 25; 1852(7):1242-52. PubMed ID: 25736301
    [Abstract] [Full Text] [Related]

  • 14. Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD.
    Montagner A, Polizzi A, Fouché E, Ducheix S, Lippi Y, Lasserre F, Barquissau V, Régnier M, Lukowicz C, Benhamed F, Iroz A, Bertrand-Michel J, Al Saati T, Cano P, Mselli-Lakhal L, Mithieux G, Rajas F, Lagarrigue S, Pineau T, Loiseau N, Postic C, Langin D, Wahli W, Guillou H.
    Gut; 2016 Jul 25; 65(7):1202-14. PubMed ID: 26838599
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Dietary medium-chain fatty acids reduce hepatic fat accumulation via activation of a CREBH-FGF21 axis.
    Cao Y, Araki M, Nakagawa Y, Deisen L, Lundsgaard A, Kanta JM, Holm S, Johann K, Brings Jacobsen JC, Jähnert M, Schürmann A, Kiens B, Clemmensen C, Shimano H, Fritzen AM, Kleinert M.
    Mol Metab; 2024 Sep 25; 87():101991. PubMed ID: 39019116
    [Abstract] [Full Text] [Related]

  • 17. Spinal Cord Injury Reduces Serum Levels of Fibroblast Growth Factor-21 and Impairs Its Signaling Pathways in Liver and Adipose Tissue in Mice.
    Liu XH, Graham ZA, Harlow L, Pan J, Azulai D, Bauman WA, Yarrow J, Cardozo CP.
    Front Endocrinol (Lausanne); 2021 Sep 25; 12():668984. PubMed ID: 34046014
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.